High Potent Pharmaceutical Development

Our comprehensive pharmaceutical development service offering includes new drug development, early stage formulation and analytical development for both highly potent and non-potent drug products.

We are able to offer API directly into capsules and vials using micro-dosing technology as well as the more traditional development pathways. The micro-dosing drug in capsule (DIC) and drug in vial (DIV) approach offers time and cost efficiencies as well as the potential to reduce wastage of often expensive APIs.

Following early stage development, we continue with further development, scale-up and process validation ahead of commercial launch for a variety of dosage forms, all supported by full in-house analytical development and release laboratory.

Our dedicated team of specialists will be happy to discuss any of your Pharmaceutical Development needs. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com

Start your PCI experience today.

Rely on our high potent pharmaceutical development services. Your drug product destination means the world to us.

talkfuture@pci.com

Spanning the cycle.A truly global proposition.

Always growing, we are driving development and connecting commercialization, and with 4300 people in 30 global GMP facilities, we are always close.